The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

We thank the members of the laboratory for their comments on the manuscript. This work was supported by National Institutes of Health grants AI34000, GM47310, and HD34440.

[1]  S. Westerheide,et al.  Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer. , 1999, Nucleic acids research.

[2]  P. J. van den Elsen,et al.  Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene , 1999, Immunogenetics.

[3]  J. M. Boss,et al.  RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. , 1999, Immunity.

[4]  J. M. Boss,et al.  CREB regulates MHC class II expression in a CIITA-dependent manner. , 1999, Immunity.

[5]  J. Ting,et al.  A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. , 1999, Immunity.

[6]  B. Peterlin,et al.  Interactions between the Class II Transactivator and CREB Binding Protein Increase Transcription of Major Histocompatibility Complex Class II Genes , 1999, Molecular and Cellular Biology.

[7]  C. Benoist,et al.  Mice lacking the transcription factor CIITA--a second look. , 1998, International immunology.

[8]  R. Aebersold,et al.  A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients , 1998, Nature Genetics.

[9]  M. Merika,et al.  Involvement of CREB Binding Protein in Expression of Major Histocompatibility Complex Class II Genes via Interaction with the Class II Transactivator , 1998, Molecular and Cellular Biology.

[10]  P. J. van den Elsen,et al.  The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. , 1998, Immunity.

[11]  P. J. van den Elsen,et al.  Regulation of MHC class I and II gene transcription: differences and similarities , 1998, Immunogenetics.

[12]  G. Stark,et al.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Reith,et al.  Genetic and molecular definition of complementation group D in MHC class II deficiency. , 1998, Human molecular genetics.

[14]  K. Rajewsky,et al.  Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. , 1998, Immunity.

[15]  C. S. Moreno,et al.  Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. , 1997, Journal of immunology.

[16]  W. Reith,et al.  Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. , 1997, The New England journal of medicine.

[17]  J. M. Boss,et al.  Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. , 1997, Journal of immunology.

[18]  S. Westerheide,et al.  HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. , 1997, Journal of immunology.

[19]  A. Peijnenburg,et al.  Site α Is Crucial for Two Routes of IFNγ-Induced MHC Class I Transactivation: The ISRE-Mediated Route and a Novel Pathway Involving CIITA , 1997 .

[20]  K. Ozato,et al.  Induction of MHC class I expression by the MHC class II transactivator CIITA. , 1997, Immunity.

[21]  C. Ucla,et al.  Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A , 1997, Human Genetics.

[22]  P. Emery,et al.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency , 1997, The EMBO journal.

[23]  R. Ransohoff,et al.  TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. , 1997, Journal of immunology.

[24]  J. Boss.  Regulation of transcription of MHC class II genes. , 1997, Current opinion in immunology.

[25]  S. Antonarakis,et al.  Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency , 1997, Human mutation.

[26]  R. Elhasid,et al.  Major histocompatibility complex class II deficiency: a clinical review. , 1996, Blood reviews.

[27]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[28]  J. M. Boss,et al.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions , 1996, Molecular and cellular biology.

[29]  R. Flavell,et al.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. , 1996, Immunity.

[30]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[31]  B. Durand,et al.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). , 1995, Genes & development.

[32]  S. Westerheide,et al.  Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). , 1995, Immunity.

[33]  L. Glimcher,et al.  Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. , 1995, Immunity.

[34]  S. Maity,et al.  Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Stark,et al.  Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. , 1994, Immunity.

[36]  R. Flavell,et al.  Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes , 1994, The Journal of experimental medicine.

[37]  B. Mach,et al.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.

[38]  Eric O Long,et al.  Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. , 1994, Journal of immunology.

[39]  A. Fischer,et al.  Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. , 1993, The Journal of pediatrics.

[40]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[41]  L. Glimcher,et al.  Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. , 1993, Journal of immunology.

[42]  J. Riley,et al.  Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells. , 1993, Journal of immunology.

[43]  R. Flavell,et al.  Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells , 1992, The Journal of experimental medicine.

[44]  W. Reith,et al.  The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters , 1992, Molecular and cellular biology.

[45]  J. M. Boss,et al.  Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. , 1992, Journal of immunology.

[46]  C. Seidl,et al.  Genetic complexity of regulatory mutants defective for HLA class II gene expression. , 1992, Journal of immunology.

[47]  J. M. Boss,et al.  Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. , 1991, Nucleic acids research.

[48]  S. Urieli-Shoval,et al.  Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients. , 1991, Journal of immunology.

[49]  J. Strominger,et al.  Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  L. Glimcher,et al.  In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. , 1991, Science.

[51]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[52]  B. Mach,et al.  Combined immunodeficiency with defective expression in MHC class II genes. , 1989, Immunodeficiency reviews.

[53]  J. M. Boss,et al.  Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Jensen.  Protein synthesis in antigen processing. , 1988, Journal of immunology.

[55]  W. Reith,et al.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X , 1988, Cell.

[56]  J. Strominger,et al.  Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[57]  B. Mach,et al.  A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes , 1985, Nature.

[58]  B. Mach,et al.  Rapid A Defect in the Regulation of Major Histocompatibility Complex Class 11 Gene Expression in Human HLA-DR Negative Lymphocytes from Patients with Combined Immunodeficiency Syndrome , 2022 .

[59]  P. Gladstone,et al.  Identification of a trans-acting function regulating HLA-DR expression in a DR-negative B cell variant , 1980, Somatic cell genetics.

[60]  P. Gladstone,et al.  Stable variants affecting B cell alloantigens in human lymphoid cells , 1978, Nature.